Core Viewpoint - Yunnan Baiyao announced the acquisition of 100% equity in Juyatang Pharmaceutical Co., Ltd. for a total consideration of 660 million yuan to enhance the development of the traditional Chinese medicine industry in Yunnan Province and expand its business nationwide [1] Group 1: Acquisition Details - The acquisition is aimed at responding to the Yunnan provincial government's call for high-quality development in the traditional Chinese medicine industry [1] - The total consideration for the acquisition is 660 million yuan [1] - Juyatang specializes in the production and sales of traditional Chinese medicine pieces, toxic traditional Chinese medicine pieces, directly consumable traditional Chinese medicine pieces, and formula granules [1] Group 2: Strategic Objectives - The acquisition aligns with the company's strategic development goals to boost the sales of traditional Chinese medicine within Yunnan Province [1] - The move is expected to facilitate the nationwide expansion of Yunnan Baiyao's related business operations [1] - The company aims to enhance the collaborative efficiency of the traditional Chinese medicine industry chain through this acquisition [1]

Group 1 - The company announced that its wholly-owned subsidiary, Yunnan Baiyao Group Traditional Chinese Medicine Resources Co., Ltd., plans to acquire 100% equity of An Guo Shi Ju Yao Tang Pharmaceutical Co., Ltd. for 660 million yuan in cash [1] - The acquisition aims to respond to the high-quality development requirements of the traditional Chinese medicine industry in Yunnan Province and align with the company's strategic development goals [1] - The acquisition is expected to enhance the sales of traditional Chinese medicine materials within Yunnan Province, accelerate the national business layout of Yunnan Baiyao, achieve scale expansion, and improve the collaborative efficiency of the traditional Chinese medicine industry chain [1] Group 2 - Ju Yao Tang specializes in the production and sales of traditional Chinese medicine pieces, toxic traditional Chinese medicine pieces, directly consumable traditional Chinese medicine pieces, and formula granules, demonstrating stable and sustainable profitability [1]